InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet and CGuard stent platform technology for the t...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 0.0% | ||
| P/E Ratio | -2.3x | ||
| Revenue | 7.009 M | ||
| Net Income to Company | -32.005 M |
| NSPR | Peers | Sector | |
|---|---|---|---|
Market Cap | 79.866 M | 167.8 M | 62.454 M |
Price % of 52 Week High | 68.3% | 64.4% | 61.1% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | -24.1% | -6.5% | -0.7% |
1 Year Price Total Return | 17.5% | -12.2% | -13.2% |
Beta (5 Year) | 0.88 | 1.22 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 5.17 | 6.21 | 7.01 | 1.76 | 1.95 |
| Operating Income | (19) | (21) | (34) | (5.81) | (9.37) |
| Net Profit | (18) | (20) | (32) | (5.41) | (9.17) |
| Diluted EPS | -2.35 | -0.82 | -0.76 | -0.16 | -0.19 |
| EBITDA | (19) | (21) | (33) | (5.75) | (9.29) |
| Balance Sheet | |||||
| Cash & ST Invest. | 18 | 39 | 35 | 39 | 35 |
| Current Assets | 21 | 44 | 41 | 44 | 41 |
| Total Assets | 25 | 48 | 47 | 48 | 47 |
| Current Liabilities | 5.07 | 6.02 | 7.68 | 6.02 | 7.68 |
| Total Liabilities | 7.26 | 8.14 | 11 | 8.14 | 11 |
| Total Equity | 17 | 40 | 36 | 40 | 36 |
| Total Debt | 1.61 | 1.59 | 2.34 | 1.59 | 2.34 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (16) | (16) | (22) | (4.18) | (6.75) |
| Cash From Investing | 8.44 | (16) | 13 | (0.04) | 8.24 |
| Cash From Financing | (0.14) | 38 | 18 | 0.00 | 1.56 |
| Free Cash Flow | (16) | (17) | (23) | (4.39) | (7.06) |